Lindsay Meyers (she/her)
@meyers711.bsky.social
Genetic Counselor 🧬 | cardio🫀, rare 🦓 | Head of Clinical Affairs at MyOme | #genechat
I read a lot ~ have too many animals ~ one kiddo
I read a lot ~ have too many animals ~ one kiddo
Reposted by Lindsay Meyers (she/her)
Join us at #ACMG2025
We will be showcasing our upcoming rare disease products in our showcase, Advancing Rare Disease Diagnostics, on March 19th at 12:15 PM PST. Lunch will be provided. Register here: lnkd.in/gP847QVR
We will be showcasing our upcoming rare disease products in our showcase, Advancing Rare Disease Diagnostics, on March 19th at 12:15 PM PST. Lunch will be provided. Register here: lnkd.in/gP847QVR
March 12, 2025 at 4:14 PM
Join us at #ACMG2025
We will be showcasing our upcoming rare disease products in our showcase, Advancing Rare Disease Diagnostics, on March 19th at 12:15 PM PST. Lunch will be provided. Register here: lnkd.in/gP847QVR
We will be showcasing our upcoming rare disease products in our showcase, Advancing Rare Disease Diagnostics, on March 19th at 12:15 PM PST. Lunch will be provided. Register here: lnkd.in/gP847QVR
Reposted by Lindsay Meyers (she/her)
🚨 New paper alert! 🚨
Using SHaRe registry data, we explored how clinical & genetic risk factors influence heart failure, arrhythmias, and mortality in men & women with HCM.
This study, from my PhD, emphasises the need for sex-specific approaches to improve care.
📖 Read more: bit.ly/41vlF9r
Using SHaRe registry data, we explored how clinical & genetic risk factors influence heart failure, arrhythmias, and mortality in men & women with HCM.
This study, from my PhD, emphasises the need for sex-specific approaches to improve care.
📖 Read more: bit.ly/41vlF9r
February 24, 2025 at 6:12 AM
🚨 New paper alert! 🚨
Using SHaRe registry data, we explored how clinical & genetic risk factors influence heart failure, arrhythmias, and mortality in men & women with HCM.
This study, from my PhD, emphasises the need for sex-specific approaches to improve care.
📖 Read more: bit.ly/41vlF9r
Using SHaRe registry data, we explored how clinical & genetic risk factors influence heart failure, arrhythmias, and mortality in men & women with HCM.
This study, from my PhD, emphasises the need for sex-specific approaches to improve care.
📖 Read more: bit.ly/41vlF9r
Reposted by Lindsay Meyers (she/her)
We're partnering with Novi Health to bring whole genome testing to employer health programs. Through this collaboration, employees and their families gain access to whole genome sequencing, integrated risk (with PRS) reports, and expert genetic counseling.
prn.to/4jzWF7T
prn.to/4jzWF7T
MyOme and Novi Health Collaborate to Bring Whole Genome Testing to Employer Health Programs
/PRNewswire/ -- MyOme, a leading clinical innovation whole genomic analysis and polygenic risk modelling (PRS) company announced a strategic partnership with...
www.prnewswire.com
January 30, 2025 at 5:04 PM
We're partnering with Novi Health to bring whole genome testing to employer health programs. Through this collaboration, employees and their families gain access to whole genome sequencing, integrated risk (with PRS) reports, and expert genetic counseling.
prn.to/4jzWF7T
prn.to/4jzWF7T
Reposted by Lindsay Meyers (she/her)
Pretty big deal. @bookshop-org.bsky.social is selling ebooks now. You can now support indies while purchasing digital books.
bookshop.org/ebooks
bookshop.org/ebooks
Bookshop.org US
Explore digital books on Bookshop.org
bookshop.org
January 28, 2025 at 12:44 PM
Pretty big deal. @bookshop-org.bsky.social is selling ebooks now. You can now support indies while purchasing digital books.
bookshop.org/ebooks
bookshop.org/ebooks
Reposted by Lindsay Meyers (she/her)
Genome sequencing in male breast cancer reveals new pathogenic variants beyond BRCA1/2, increasing diagnostic yield to 33% and highlighting polygenic and monogenic contributions to disease risk bit.ly/3CbJXLx
January 9, 2025 at 9:38 PM
Genome sequencing in male breast cancer reveals new pathogenic variants beyond BRCA1/2, increasing diagnostic yield to 33% and highlighting polygenic and monogenic contributions to disease risk bit.ly/3CbJXLx
Reposted by Lindsay Meyers (she/her)
Another study shows cardiovascular genetic testing (CVGT) underutilization and provides new evidence of genetic counseling (GC) underutilization. Sneak peek at cardiomyopathy (CM) and arrhythmia (ARRH) data: 1% with CM and 0.7% with ARRH had GC; only 0.84% had GT. pubmed.ncbi.nlm.nih.gov/37766662/
A health systems assessment of genetic counseling in cardiovascular care in a large health system: Adherence to genetics recommendations in the Military Health System - PubMed
Genetic counseling and genetic testing are important tools for diagnosis, screening, and employment of effective medical management strategies for hereditary cardiovascular diseases. Despite widesprea...
pubmed.ncbi.nlm.nih.gov
December 16, 2024 at 3:53 PM
Another study shows cardiovascular genetic testing (CVGT) underutilization and provides new evidence of genetic counseling (GC) underutilization. Sneak peek at cardiomyopathy (CM) and arrhythmia (ARRH) data: 1% with CM and 0.7% with ARRH had GC; only 0.84% had GT. pubmed.ncbi.nlm.nih.gov/37766662/
Reposted by Lindsay Meyers (she/her)
🎉 The HEARTS Act has passed the Senate & heads to President Biden's desk! HRS, a proud Smart Heart Sports Coalition member, led a grassroots effort urging legislators to act. Soon, schools nationwide will have AEDs, CPR training, & emergency plans—lifesaving tools for every kid ❤️smartheartsports.com
December 12, 2024 at 2:12 PM
🎉 The HEARTS Act has passed the Senate & heads to President Biden's desk! HRS, a proud Smart Heart Sports Coalition member, led a grassroots effort urging legislators to act. Soon, schools nationwide will have AEDs, CPR training, & emergency plans—lifesaving tools for every kid ❤️smartheartsports.com
Reposted by Lindsay Meyers (she/her)
Big news! 🧬 Natera & MyOme launch iPRS™, a personalized tool to assess breast cancer risk. Backed by research, iPRS integrates >1M genetic markers & clinical inputs for accurate, cross-ancestry insights.
Learn more: ow.ly/mGsJ50UntLt
#BreastCancer #Genetics
Learn more: ow.ly/mGsJ50UntLt
#BreastCancer #Genetics
Natera and MyOme Announce Launch of iPRS™ for Breast Cancer Risk Assessment
Cross-ancestry polygenic risk score now offered with the Empower™ hereditary cancer test AUSTIN, Texas–(BUSINESS WIRE)– Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testin...
ow.ly
December 9, 2024 at 5:38 PM
Big news! 🧬 Natera & MyOme launch iPRS™, a personalized tool to assess breast cancer risk. Backed by research, iPRS integrates >1M genetic markers & clinical inputs for accurate, cross-ancestry insights.
Learn more: ow.ly/mGsJ50UntLt
#BreastCancer #Genetics
Learn more: ow.ly/mGsJ50UntLt
#BreastCancer #Genetics
Reposted by Lindsay Meyers (she/her)
Sharing the @americanheart.bsky.social scientific statement about asssessing & addressing CV health in individuals who are transgender and gender diverse. Transgender care is health care, and I support optimizing the lives & hearts of all persons. 🏳️🌈
www.ahajournals.org/doi/10.1161/...
www.ahajournals.org/doi/10.1161/...
December 4, 2024 at 2:16 PM
Sharing the @americanheart.bsky.social scientific statement about asssessing & addressing CV health in individuals who are transgender and gender diverse. Transgender care is health care, and I support optimizing the lives & hearts of all persons. 🏳️🌈
www.ahajournals.org/doi/10.1161/...
www.ahajournals.org/doi/10.1161/...
Reposted by Lindsay Meyers (she/her)
black or female, test lp(a)
'One-third of participants demonstrated Lp(a) levels ≥125 nmol/L, the threshold for high ASCVD risk, which was higher among Black (1/2) and female (2/5) participants, suggesting a greater need for Lp(a) testing'
#cardiosky #cvprev
www.lipidjournal.com/article/S193...
'One-third of participants demonstrated Lp(a) levels ≥125 nmol/L, the threshold for high ASCVD risk, which was higher among Black (1/2) and female (2/5) participants, suggesting a greater need for Lp(a) testing'
#cardiosky #cvprev
www.lipidjournal.com/article/S193...
Lipoprotein(a) levels in a population with clinical atherosclerotic cardiovascular disease in the United States: A subanalysis from the Lp(a)HERITAGE study
Cardiovascular disease (CVD) is the leading cause of death worldwide, responsible for an estimated 27% of deaths in the United States (US) in 2021.1 Globally, almost 20 million deaths were caused by CVD in 2021, which represents an increase of approximately 21% since 2010.1 Elevated lipoprotein(a) (Lp[a]) is the most common genetic dyslipidemia,2 affecting approximately 1.5 billion people worldwide. Evidence from both epidemiological and genetic studies identifies elevated Lp(a) as independently and causally associated with increased atherosclerotic cardiovascular disease (ASCVD) risk.
www.lipidjournal.com
December 5, 2024 at 2:30 AM
black or female, test lp(a)
'One-third of participants demonstrated Lp(a) levels ≥125 nmol/L, the threshold for high ASCVD risk, which was higher among Black (1/2) and female (2/5) participants, suggesting a greater need for Lp(a) testing'
#cardiosky #cvprev
www.lipidjournal.com/article/S193...
'One-third of participants demonstrated Lp(a) levels ≥125 nmol/L, the threshold for high ASCVD risk, which was higher among Black (1/2) and female (2/5) participants, suggesting a greater need for Lp(a) testing'
#cardiosky #cvprev
www.lipidjournal.com/article/S193...
Reposted by Lindsay Meyers (she/her)
Great collaborative work spearheaded by M. Ardissino showing that, among those sustaining early-onset myocardial infarction, a CAD polygenic risk score was the strongest among assessed predictors of recurrent events www.ahajournals.org/doi/10.1161/... @ahajournals.bsky.social
November 30, 2024 at 2:24 PM
Great collaborative work spearheaded by M. Ardissino showing that, among those sustaining early-onset myocardial infarction, a CAD polygenic risk score was the strongest among assessed predictors of recurrent events www.ahajournals.org/doi/10.1161/... @ahajournals.bsky.social
Reposted by Lindsay Meyers (she/her)
The GLGC is a global collaboration of 100s of scientists interested in lipid genetics. Check out our recent review, where we highlight 🔑 contributions from the GLGC across the last 15 years.
👇
#CardioSky #Genetics #Lipids #GWAS
👇
#CardioSky #Genetics #Lipids #GWAS
Our review led by @jsdron.bsky.social of the contributions of the Global Lipids Genetics Consortium (www.lipidgenetics.org) journals.lww.com/co-lipidolog...
December 2, 2024 at 6:23 PM
The GLGC is a global collaboration of 100s of scientists interested in lipid genetics. Check out our recent review, where we highlight 🔑 contributions from the GLGC across the last 15 years.
👇
#CardioSky #Genetics #Lipids #GWAS
👇
#CardioSky #Genetics #Lipids #GWAS
Reposted by Lindsay Meyers (she/her)
I couldn't spot a starter pack for rare disease / clinical genomics, so I started one: go.bsky.app/SUWZ9Hw
Very much a work in progress, and biased by who I have already found here, so please suggest people to add! Self-nominations encouraged.
#ClinicalInformatics #genomics #bioinformatics 🖥️🧬
Very much a work in progress, and biased by who I have already found here, so please suggest people to add! Self-nominations encouraged.
#ClinicalInformatics #genomics #bioinformatics 🖥️🧬
November 15, 2024 at 10:30 AM
I couldn't spot a starter pack for rare disease / clinical genomics, so I started one: go.bsky.app/SUWZ9Hw
Very much a work in progress, and biased by who I have already found here, so please suggest people to add! Self-nominations encouraged.
#ClinicalInformatics #genomics #bioinformatics 🖥️🧬
Very much a work in progress, and biased by who I have already found here, so please suggest people to add! Self-nominations encouraged.
#ClinicalInformatics #genomics #bioinformatics 🖥️🧬
Reposted by Lindsay Meyers (she/her)
Among British Pakistani & British Bangladeshi individuals, partitioned T2D polygenic load for insulin deficiency & lipodystrophy was higher than white European individuals & predisposed to faster progression to T2D & complications www.nature.com/articles/s41... @natureportfolio.bsky.social
November 26, 2024 at 2:04 PM
Among British Pakistani & British Bangladeshi individuals, partitioned T2D polygenic load for insulin deficiency & lipodystrophy was higher than white European individuals & predisposed to faster progression to T2D & complications www.nature.com/articles/s41... @natureportfolio.bsky.social